All In Biotech

Free tool

FAERS Monitor: Erbitux

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 125084 or its brand name (Erbitux, Cetuximab). Reports on generic versions are filed under their own applications.

Reports

31,703

Serious

27,066

85% of reports

Hospitalization

12,726

Death reported

4,267

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • rash2,287
  • diarrhoea2,049
  • off label use1,923
  • nausea1,677
  • vomiting1,415
  • dyspnoea1,411
  • neutropenia1,243
  • pyrexia1,137
  • malignant neoplasm progression1,136
  • infusion related reaction1,113
  • dehydration1,106
  • fatigue1,096
  • death1,084
  • hypotension940
  • anaemia935

Reports by year received

View as table
YearReports
2004691
20051,076
20061,313
20071,079
20081,212
20091,407
20101,576
20111,639
20121,656
20131,541
20141,570
20151,412
20161,537
20171,913
20181,472
20191,437
20201,152
20211,237
20221,283
20231,385
20241,371
20251,471
20261,273

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,022,456 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
infusion related reactionSignal1,11311.310.710,310
malignant neoplasm progressionSignal1,1367.47.06,276
neutropeniaSignal1,2436.15.85,295
dehydrationSignal1,1065.55.24,101
rashSignal2,2873.53.44,133
anaemiaSignal9353.33.11,472
hypotensionSignal9403.12.91,358
pyrexiaSignal1,1372.22.1738
diarrhoeaSignal2,0492.12.01,228
vomiting1,4152.01.9720
dyspnoea1,4111.71.6375
off label use1,9231.51.4288
nausea1,6771.41.3204
fatigue1,0960.90.95
death1,0840.80.837

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.